CAS NO: | 1428569-85-0 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | GDC-0339 is a potent, orally bioavailable and well toleratedpan-Pim kinaseinhibitor, withKis of 0.03 nM, 0.1 nM and 0.02 nM forPim1,Pim2andPim3, respectively. GDC-0339 is discovered as a potential treatment of multiple myeloma[1][2]. | ||||||||||||||||
IC50& Target | Ki: 0.03 nM (Pim1), 0.1 nM (Pim2), 0.02 nM (Pim3)[2] | ||||||||||||||||
体外研究 (In Vitro) | GDC-0339 is cytostatic, with an IC50of 0.1 μM for MM.1S cells[2]. Cell Viability Assay[2]
Western Blot Analysis[2]
| ||||||||||||||||
体内研究 (In Vivo) | GDC-0339 (1-300 mg/kg; p.o; daily; for 21 days) is efficacious in RPMI8226 and MM.1S human multiple myeloma xenograft mouse models[2].
| ||||||||||||||||
分子量 | 465.50 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H22F3N7OS | ||||||||||||||||
CAS 号 | 1428569-85-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 52 mg/mL(111.71 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |